Executive Director UBImedical & CEO of NeuroSoV
NeuroSoV
NeuroSoV is developing disease-modifying treatments for neurological disorders, with a focus on Parkinson's Disease. Their lead candidate targets NADPH oxidase 1 (NOX1) to reduce oxidative stress and delay disease progression in Parkinson's patients.
- Software Only
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- Okay, I understand. I will analyze the provided information, extract the key elements, and generate a startup description that adheres to the specified structure, content, and style guidelines. I will focus on clarity, accuracy, and the use of appropriate technical terminology. I will also ensure that the description avoids any prohibited information.